Page 44 - Read Online

Page 10 of 10 Dong et al. Neuroimmunol Neuroinflammation 2018;5:5 I http://dx.doi.org/10.20517/2347-8659.2017.47

TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 2005;348:575-88.
13. Buratti E, Brindisi A, Pagani F, Baralle FE. Nuclear factor tdp-43 binds to the polymorphic tg repeats in cftr intron 8 and causes skipping of
exon 9: a functional link with disease penetrance. Am J Hum Genet 2004;74:1322-5.
14. Ayala YM, Zago P, Ambrogio AD, Xu YF, Petrucelli L, Buratti E, Baralle F. Structural determinants of the cellular localization and shuttling
of TDP-43. J Cell Sci 2008;121:3778-85.
15. Ayala YM, Pagani F, Baralle FE. Tdp43 depletion rescues aberrant cftr exon 9 skipping. FEBS Lett 2006;580:1339-44.
16. Tan Q, Yalamanchili HK, Park J, De Maio A, Lu HC, Wan YW, White JJ, Bondar VV, Sayegh LS, Liu X, Gao Y, Sillitoe RV, Orr HT, Liu Z,
Zoghbi HY. Extensive cryptic splicing upon loss of rbm17 and tdp43 in neurodegeneration models. Hum Mol Genet 2016;25:5083-93.
17. Gendron TF, Petrucelli L. Rodent models of tdp-43 proteinopathy: investigating the mechanisms of tdp-43-mediated neurodegeneration. J
Mol Neurosci 2011;45:486-99.
18. Herhaus L, Dikic I. Expanding the ubiquitin code through post-translational modification. EMBO Rep 2015;16:1071-83.
19. Buratti E, Baralle FE. The molecular links between tdp-43 dysfunction and neurodegeneration. Adv Genet 2009;66:1-34.
20. Yan S, Wang CE, Wei W, Gaertig MA, Lai L, Li S, Li XJ. Tdp-43 causes differential pathology in neuronal versus glial cells in the mouse
brain. Hum Mol Genet 2014;23:2678-93.
21. Okamoto K, Fujita Y, Mizuno Y. Pathology of protein synthesis and degradation systems in als. Neuropathology 2010;30:189-93.
22. Tank EM, True HL. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
PLoS Genet 2009;5:e1000382.
23. Barmada SJ. Cytoplasmic mislocalization of tdp-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic
lateral sclerosis. J Neurosci 2010;30:639-49.
24. Lim L, Wei Y, Lu Y, Song J. Als-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the
intrinsically disordered prion-like domain of tdp-43. PLoS Biol 2016;14:e1002338.
25. Barmada SJ, Finkbeiner S. Pathogenic tardbp mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated
pathways. Rev Neurosci 2010;21:251-72.
26. Barmada SJ, Serio A, Arjun A, Bilican B, Daub A, Ando DM, Tsvetkov A, Pleiss M, Li X, Peisach D, Shaw C, Chandran S, Finkbeiner S.
Autophagy induction enhances tdp43 turnover and survival in neuronal als models. Nat Chem Biol 2014;10:677-85.
27. Kim PY, Tan O, Liu B, Trahair T, Liu T, Haber M, Norris MD, Marshall GM, Cheung BB. High tdp43 expression is required for trim16-
induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Cancer Lett
2016;374:315-23.
28. Bhandare VV, Ramaswamy A. The proteinopathy of d169g and k263e mutants at the RNA recognition motif (RRM) domain
of tar DNA-binding protein (tdp43) causing neurological disorders: a computational study. J Biomol Struct Dyn 2017; doi:
10.1080/07391102.2017.1310670
29. Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S, Yoshida M, Katsuno M, Sobue G, Julien JP. Exosome secretion is
a key pathway for clearance of pathological tdp-43. Brain 2016;139:3187-201.
30. Pokrishevsky E, Grad LI, Yousefi M, Wang J, Mackenzie IR, Cashman NR. Aberrant localization of fus and tdp43 is associated with
misfolding of sod1 in amyotrophic lateral sclerosis. PLoS One 2014;7:e35050.
31. Pokrishevsky E, Grad LI, Cashman NR. TDP-43 or FUS-induced misfolded human wild-type sod1 can propagate intercellularly in a prion-
like fashion. Sci Rep 2016;6:22155.
32. Shintaku M, Kaneda D, Oyanagi K. Novel intracytoplasmic inclusions immunoreactive for phosphorylated-TDP43 and cystatin c in anterior
horn cells in a case of sporadic amyotrophic lateral sclerosis. Neuropathology 2017;37:526-34.
33. Gros-Louis F, Gaspar C, Rouleau GA. Sporadic and hereditary amyotrophic lateral sclerosis. Biochim Biophys Acta 2015;1852:679-84.
34. Braun RJ. Ubiquitin-dependent proteolysis in yeast cells expressing neurotoxic proteins. Front Mol Neurosci 2015;8:8.
35. Wang W, Arakawa H, Wang L, Okolo O, Siedlak SL, Jiang Y, Gao J, Xie F, Petersen RB, Wang X. Motor-coordinative and cognitive
dysfunction caused by mutant TDP-43 could be reversed by inhibiting its mitochondrial localization. Mol Ther 2017;25:127-39.
36. Hebron ML, Lonskaya I, Sharpe K, Weerasinghe PP, Algarzae NK, Shekoyan AR, Moussa CE. Parkin ubiquitinates Tar-DNA binding
protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6). J Biol Chem
2013;288:4103-15.
37. Jackson KL, Dayton RD, Orchard EA, Ju S, Ringe D, Petsko GA, Maquat LE, Klein RL. Preservation of forelimb function by UPF1 gene
therapy in a rat model of TDP-43-induced motor paralysis. Gene Ther 2015;22:20-8.
38. Park SK, Hong JY, Arslan F, Kanneganti V, Patel B, Tietsort A, Tank EMH, Li X, Barmada SJ, Liebman SW. Overexpression of the essential
Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis. PLoS Genet 2017;13:e1006805.